Ashton Thomas Securities’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Ashton Thomas Securities's RGEN Position: Q4 2024 in Review
Ashton Thomas Securities sold out of Repligen (RGEN) in Q4 2024, closing a stake of 13 shares — an estimated $1.94K sold.
Ashton Thomas Securities first reported a position in RGEN in Q3 2024 and held it in 1 quarter. The position peaked at $1.94K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.
- Ashton Thomas Securities reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
- Ashton Thomas Securities sold 13 Repligen shares in Q4 2024, an estimated $1.94K.
- Ashton Thomas Securities first reported a position in Repligen in Q3 2024 and held it in 1 quarter.
- Ashton Thomas Securities's Repligen position peaked at $1.94K in Q3 2024.
- 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.
Based on Ashton Thomas Securities's 13F filing for Q4 2024, filed 11 Feb 2025.